Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study
Matthew J. Ellis, Feng Gao, Farrokh Dehdashti, Donna B. Jeffe, P. Kelly Marcom, Lisa A. Carey, Maura N. Dickler, Paula Silverman, Gini F. Fleming, Aruna Kommareddy, S. Jamalabadi-Majidi, Robert Crowder, Barry A. Siegel
Dive into the research topics of 'Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: A phase 2 randomized study'. Together they form a unique fingerprint.